Indaptus Therapeutics
INDP
INDP
6 hedge funds and large institutions have $12.9M invested in Indaptus Therapeutics in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
6
Holders Change
-2
Holders Change %
-25%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
PA
1
Perceptive Advisors
New York
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$11K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $3.72M | 809,804 | +9,804 | +1% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $3.35M | 743,545 | +29,483 | +4% |
|
|
OM
3
Opaleye Management
Boston,
Massachusetts
| $2.99M | 650,000 | +12,000 | +2% |
|
|
MIFH
4
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $2.28M | 495,000 | +495,000 | New |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| $549K | 119,296 | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $11K | 2,346 | -556 | -19% |
|
|
PA
7
Perceptive Advisors
New York
| – | – | -192,580 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | – | -712 | Closed |
|
9
Morgan Stanley
New York
| – | – | -19 | Closed |
|